All Stories

  1. Antirheumatic medication use among pregnant women with rheumatoid arthritis: a Norwegian nationwide drug utilisation study
  2. Bridging affordability and sustainability of health innovations via novel pricing, cost-effectiveness, and reimbursement models to improve patient access: The ASCERTAIN project
  3. Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer
  4. 50 Studies Every Hospitalist Should Know
  5. Comparing supervised machine learning algorithms for the prediction of partial arterial pressure of oxygen during craniotomy
  6. Comparing supervised machine learning algorithms for the prediction of partial arterial pressure of oxygen during craniotomy
  7. Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study
  8. Predicting Successful Weaning from Mechanical Ventilation by Reduction in Positive End-expiratory Pressure Level Using Machine Learning
  9. COVID-19 and pregnancy: A European study on pre- and post-infection medication use
  10. Predicting Hypoxia Using Machine Learning: Systematic Review
  11. Comparing Supervised Machine Learning Algorithms for the Prediction of Partial Arterial Pressure of Oxygen During Craniotomy
  12. Handheld Lung Ultrasound to Detect COVID-19 Pneumonia in Inpatients: A Prospective Cohort Study
  13. Use of Urea for the Syndrome of Inappropriate Secretion of Antidiuretic Hormone
  14. Impact of COVID-19 Policies on Hospitalists’ Psychological Safety
  15. Cost associated with diverting ostomy after rectal cancer surgery: a transnational analysis
  16. Evaluating disparities in code status designation among patients admitted with COVID-19 at a quaternary care center early in the pandemic
  17. Cost-effectiveness of transcatheter aortic valve implantation in patients at low surgical risk in France: a model-based analysis of the Evolut LR trial
  18. Blockchain-enabled immutable, distributed, and highly available clinical research activity logging system for federated COVID-19 data analysis from multiple institutions
  19. Evaluating disparities by social determinants in hospital admission decisions for patients with COVID-19 quaternary hospital early in the pandemic
  20. Discharge to post–acute care and other predictors of prolonged length of stay during the initial COVID-19 surge: a single site analysis
  21. Coronary artery disease and revascularization associated with immune checkpoint blocker myocarditis: Report from an international registry
  22. Impact of Hurricanes and Associated Extreme Weather Events on Cardiovascular Health: A Scoping Review
  23. IN.PACT AV Access Trial: Economic Evaluation of Drug-Coated Balloon Treatment for Dysfunctional Arteriovenous Fistulae Based on 12-Month Clinical Outcomes
  24. Costs and cost-effectiveness of HIV early infant diagnosis in low- and middle-income countries: a scoping review
  25. Comparing supervised machine learning algorithms for the prediction of partial arterial pressure of oxygen during craniotomy
  26. The Effect of Standardized Hospitalist Information Cards on the Patient Experience: a Quasi-Experimental Prospective Cohort Study
  27. A Diagnostic Model for Kawasaki Disease Based on Immune Cell Characterization From Blood Samples
  28. Cost-Effectiveness of Urea Excipient-Based Drug-Coated Balloons for Chronic Limb-Threatening Ischemia from Femoropopliteal Disease in the Netherlands and Germany
  29. Case management in a COVID ‐19 surge: A single‐institution study of disposition and access to post‐acute ...
  30. Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 Pandemic
  31. Letter to the editor regarding Extracorporeal membrane oxygenation for COVID-19: a systematic review and meta-analysis
  32. Racial/ethnic and socioeconomic variations in hospital length of stay
  33. Repurposing existing medications for coronavirus disease 2019: protocol for a rapid and living systematic review
  34. A Simplified Point-of-Care Lung Ultrasound Protocol to Detect Coronavirus Disease 2019 in Inpatients: A Prospective Observational Study
  35. An assessment of annual procedure volumes and therapy adoption of transcatheter closure of patent foramen ovale in four European countries
  36. Blood pressure control in Australian general practice: analysis using general practice records of 1.2 million patients from the MedicineInsight database
  37. Twelfth European Students’ Conference
  38. Hydroxychloroquine Toxicity
  39. Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review
  40. Cost-effectiveness of transcatheter versus surgical aortic valve replacement in patients at lower surgical risk: results from the NOTION trial
  41. Study Comparing Traditional Versus Alternative Metrics to Measure the Impact of the Critical Care Medicine Literature
  42. Model to evaluate the impact of hospital-based interventions targeting false-positive blood cultures on economic and clinical outcomes
  43. Utilizing a PLASMIC score‐based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative
  44. Clinical and Economic Benefits of Upper Airway Stimulation for Obstructive Sleep Apnea in a European Setting
  45. Prior Statin Use Is Associated with Decreased Mortality and Lower Levels of Liver and Brain Organ Failure Scores in Sepsis - A Matched Observational Study
  46. Adoption Patterns of Bronchoscopic Lung Volume Reduction Procedures in Germany and Predicted Procedure Volumes for Other European Countries
  47. Should Surgical Repair Be Recommended Over Nonoperative Management for Medial Meniscus Root Tears? Response
  48. Meniscus Root Repair vs Meniscectomy or Nonoperative Management to Prevent Knee Osteoarthritis After Medial Meniscus Root Tears: Clinical and Economic Effectiveness
  49. Outcomes of Ventilated Patients With Sepsis Who Undergo Interhospital Transfer
  50. Racial and Geographic Disparities in Interhospital ICU Transfers*
  51. Correction to: Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan
  52. Cost-Effectiveness and Projected Survival of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement for High Risk Patients in a European Setting: A Dutch Analysis Based on the CoreValve High Risk Trial
  53. Cost-effectiveness of orbital atherectomy compared to rotational atherectomy in treating patients with severely calcified coronary artery lesions in Japan
  54. Response to Lee et al.
  55. Cost-Effectiveness of a Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
  56. Value in Oral and Maxillofacial Surgery: A Systematic Review of Economic Analyses
  57. Economic Analysis of Endovascular Interventions for The Treatment of Femoropopliteal Peripheral Artery Disease in Austria
  58. Dyspnea and Chest Pain in a Young Woman Caused by a Giant Pericardial Lymphohemangioma: Diagnosis and Treatment
  59. Economic analysis of endovascular drug-eluting treatments for femoropopliteal artery disease in the UK
  60. COST EFFECTIVENESS OF TRANSCATHETER AORTIC VALVE IMPLANTATION VERSUS SURGICAL AORTIC VALVE REPLACEMENT: THE COREVALVE HIGH RISK TRIAL FROM A DUTCH PERSPECTIVE
  61. Economic Analysis of Drug-Coated Balloons And Other Endovascular Treatments For Femoropopliteal Artery Disease In The United Kingdom
  62. Cardiovascular Benefits of the Mediterranean Diet Are Driven by Stroke Reduction and Possibly by Decreased Atrial Fibrillation Incidence
  63. Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease: Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence
  64. Cost-Effectiveness of Transcatheter Aortic Valve Replacement: Current Decision-Analytic Models and Future Opportunities
  65. Adoption Of Transcatheter Aortic Valve Replacement In Germany: Utilization Patterns And Case Volumes Compared To Surgical Aortic Valve Replacement In The Period 2009-2013
  66. TCT-157 The Impact of transcatheter aortic valve replacement on therapy utilization and case volumes in Germany, 2009-2013
  67. COMPARATIVE SAFETY OF INTRAVENOUS NICARDIPINE INFUSION IN PATIENTS WITH AND WITHOUT SYSTOLIC DYSFUNCTION
  68. Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
  69. Do Insurers Compete on the Federal Health Insurance Exchange?
  70. Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study
  71. Estimated Added Benefit Of Catheter-Based Renal Denervation For Moderate Treatment-Resistant Hypertension: Impact Of Age And Cardiovascular Risk Factors
  72. Gabapentin Treatment for Alcohol Dependence
  73. Economic analysis of endovascular interventions for femoropopliteal arterial disease: A systematic review and budget impact model for the United States and Germany
  74. GIANT CARDIAC LYMPHANGIOMA WITH COMPLETE ENCASEMENT OF THE RIGHT CORONARY ARTERY: IMAGING AND THERAPEUTIC APPROACH
  75. Correction
  76. Health-Economic Assessment of the Use of Catheter-Based Renal Denervation in Patients with Resistant Hypertension in Mexico
  77. Cost-effectiveness of catheter-based renal denervation for resistant hypertension – a canadian perspective
  78. PMD20 Budget Impact of Drug Eluting Balloons for Intermittent Claudication From Superficial Femoral Artery Disease in the United States Health Care System
  79. PMD23 Long-Term Clinical Effectiveness and Cost-Effectiveness of Catheter-Based Renal Denervation in the UK. A Model-Based Projection Based on the Symplicity HTN-2 Trial
  80. Cost-Effectiveness and Clinical Effectiveness of Catheter-Based Renal Denervation for Resistant Hypertension
  81. PMD57 New Approaches for Graphing Probabilistic Patient-Relevant Health Outcomes: The Case of Renal Denervation for Resistant Hypertension
  82. EFFICACY AND CLINICAL AND ECONOMIC EFFECTIVENESS IN RESISTANT HYPERTENSIVE SUBGROUPS
  83. Trauma and Burn Education: A Global Survey
  84. Correction: Use of Observation Care in US Emergency Departments, 2001 to 2008
  85. Determining Health-Related Quality of Life and Health State Utility Values of Urinary Incontinence in Women
  86. Use of Observation Care in US Emergency Departments, 2001 to 2008
  87. Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure
  88. Perspectives on “Early Dialogue” between a Manufacturer and Health Technology Assessment Agencies
  89. Treating anemia in heart failure patients: a review of erythropoiesis-stimulating agents
  90. Leadership in health care
  91. Health State Survey-Derived Utilities in Cost-Utility Analysis—A Call to Action
  92. Estimates of Electronic Medical Records in U.S. Emergency Departments
  93. Gesundheitsökonomische Evaluation der INH (interdisziplinäres Netzwerk Herzinsuffizienz)-Studie
  94. Risk of bias in meta-analysis on erythropoietin-stimulating agents in heart failure
  95. Additional Factors That Could Improve Cost-Effectiveness of Pharmacogenetic-Guided Dosing in Warfarin Therapy
  96. PHP9 THE IMPACT OF LEGISLATION AND PRICING ON GENERIC DRUG UTILIZATION: AN ANALYSIS OF 26 COUNTRIES
  97. Deterministic Sensitivity Analysis for First-Order Monte Carlo Simulations: A Technical Note
  98. Utility Estimates for Decision–Analytic Modeling in Chronic Heart Failure—Health States Based on New York Heart Association Classes and Number of Rehospitalizations
  99. Decision‐analytic evaluation of the clinical effectiveness and cost‐effectiveness of management programmes in chronic heart failure